{
    "code": "71000012",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=71000012",
    "time": "2020-02-26 10:00:57",
    "許可證字號": "衛部罕藥製字第000012號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/06\/17",
    "發證日期": "103\/06\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY07100001207",
    "中文品名": "沙立邁膠囊50毫克",
    "英文品名": "Thalimide Capsules 50mg",
    "適應症": "痲瘋性結節性紅斑(Erythema Nodosum Leprosum, ENL)。Thalidomide可用於中度至重度ENL出現皮膚徵兆之急性期治療。亦可持續用於預防及抑制ENL皮膚徵兆復發。不可單獨用於治療發生中度至重度神經炎之ENL。",
    "劑型": "130膠囊劑",
    "包裝": "4-1000粒塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 24監視期滿學名藥",
        "申請商名稱": "0901301200  美時化學製藥股份有限公司",
        "申請商地址": "台北市信義區松仁路277號17樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200028000",
            "成分名稱": "THALIDOMIDE",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "沙立邁膠囊50毫克_仿單_2015-10-27-104-11-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=71000012&Seq=002&Type=9"
        },
        {
            "title": "沙立邁膠囊50毫克_外盒_20151027-104-11-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=71000012&Seq=003&Type=8"
        }
    ]
}